Truist maintains Buy on Amentum stock, reiterates $31 target
Truist Securities sustained its optimistic stance on Amentum Holdings Inc. (NYSE:AMTM) following the company's release of favorable first-quarter 2025 results. With current revenue of $9.82 billion ...
Truist Financial Remains a Hold on Doximity (DOCS)
Truist Financial analyst Jailendra Singh maintained a Hold rating on Doximity (DOCS – Research Report) today. The company’s shares closed ...
Truist Financial Remains a Buy on MGM Resorts (MGM)
Truist Financial analyst Barry Jonas maintained a Buy rating on MGM Resorts (MGM – Research Report) today. The company’s shares closed ...
Fintel on MSN6d
Truist Securities Upgrades Pacira BioSciences (PCRX)
Fintel reports that on January 30, 2025, Truist Securities upgraded their outlook for Pacira BioSciences (NasdaqGS:PCRX) from ...